Contemporary trends in survival in multiple sclerosis in the US: study design and rationale

被引：0
|
作者：
Cutter, G.
Reshef, S.
Golub, H.
Kaufman, D.
Brueckner, A.
Preblick, R.
Knappertz, V.
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Bayer HealthCare Pharmaceut Inc, Montville, NJ USA
[3] Care Safe LLC, Newton, MA USA
[4] Slone Epidemiol Ctr, Boston, MA USA
[5] Bayer Schering Pharma AG, Elbonfeld, DE USA
[6] Bayer HealthCare Pharmaceut Inc, Wayne, NJ USA
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P237
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [1] Mortality and survival trends in US multiple sclerosis patients
    Reshef, S.
    Cutter, G.
    Kaufman, D. W.
    Golub, H.
    Preblick, R.
    Bruckner, A.
    Knappertz, V.
    JOURNAL OF NEUROLOGY, 2011, 258 : 98 - 99
  • [2] Mortality and Survival Trends in Multiple Sclerosis as Observed in a Large Insured US Cohort and a Multiple Sclerosis Registry
    Reshef, Shoshana
    Kaufman, David
    Golub, Howard
    Cutter, Gary
    Bruckner, Andreas
    Preblick, Ronald
    Knappertz, Volker
    NEUROLOGY, 2011, 76 (09) : A476 - A476
  • [3] Contemporary trends of rehabilitation in multiple sclerosis
    Opara, Jozef
    Szwejkowski, Waldemar
    Brola, Waldemar
    AKTUALNOSCI NEUROLOGICZNE, 2009, 9 (02): : 140 - 146
  • [4] Early treatment in multiple sclerosis with intravenous immunoglobulin: Rationale and study design
    Achiron, A
    Barak, Y
    Faibel, M
    Miron, S
    Kishner, I
    Chen, M
    Stern, Y
    Sarova-Pinhas, I
    EARLY INDICATORS, EARLY TREATMENTS, NEUROPROTECTION IN MULTIPLE SCLEROSIS, 2003, : 119 - 128
  • [5] Mortality in Multiple Sclerosis in the United States (MIMS-US): A Retrospective, Cohort Study of Survival and Mortality Trends
    Reshef, Shoshana
    Cutter, Gary
    Golub, Howard
    Brueckner, Andreas
    Knappertz, Volker
    NEUROLOGY, 2012, 78
  • [6] SURVIVAL TRENDS IN MULTIPLE MYELOMA: A US POPULATION-BASED STUDY
    Budhathoki, Nibash
    Shah, Binay K.
    ANTICANCER RESEARCH, 2016, 36 (12) : 6708 - 6708
  • [7] The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis Rationale, study design, and methodology
    Russo, Margherita
    Dattola, Vincenzo
    Logiudice, Anna Lisa
    Ciurleo, Rosella
    Sessa, Edoardo
    De Luca, Rosaria
    Bramanti, Placido
    Bramanti, Alessia
    Naro, Antonino
    Calabro, Rocco Salvatore
    MEDICINE, 2017, 96 (46)
  • [8] Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
    Comi, Giancarlo
    Battaglia, Mario Alberto
    Bertolotto, Antonio
    Del Sette, Massimo
    Ghezzi, Angelo
    Malferrari, Giovanni
    Salvetti, Marco
    Sormani, Maria Pia
    Tesio, Luigi
    Stolz, Erwin
    Mancardi, Gianluigi
    NEUROLOGICAL SCIENCES, 2013, 34 (08) : 1297 - 1307
  • [9] Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
    Giancarlo Comi
    Mario Alberto Battaglia
    Antonio Bertolotto
    Massimo Del Sette
    Angelo Ghezzi
    Giovanni Malferrari
    Marco Salvetti
    Maria Pia Sormani
    Luigi Tesio
    Erwin Stolz
    Gianluigi Mancardi
    Neurological Sciences, 2013, 34 : 1297 - 1307
  • [10] The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
    Oh, Jiwon
    Arbour, Nathalie
    Giuliani, Fabrizio
    Guenette, Melanie
    Kolind, Shannon
    Lynd, Larry
    Marrie, Ruth Ann
    Metz, Luanne M.
    Patten, Scott B.
    Prat, Alexandre
    Schabas, Alice
    Smyth, Penelope
    Tam, Roger
    Traboulsee, Anthony
    Yong, V. Wee
    BMC NEUROLOGY, 2021, 21 (01)
12345